当前位置:首页 - 行情中心 - 迈威生物-U(688062) - 财务分析

迈威生物-U

(688062)

  

流通市值:71.87亿  总市值:157.25亿
流通股本:2.04亿   总股本:4.47亿

迈威生物-U(688062)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润-2.43亿元,每股收益-0.61元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益28921.09万元,未分配利润-600654.59万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产456834.73万元,负债427913.64万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入127,597,218.83662,515,554.62565,838,248.14101,165,449.14
营业总成本356,747,236.671,634,418,367.371,164,855,191.83671,700,790.36
其他经营收益
营业利润-238,881,544.3-955,317,716-582,936,935.76-552,442,829.55
利润总额-240,151,217.82-956,393,708.06-582,677,606.59-552,175,797.82
净利润-243,042,847.72-972,257,776.24-599,596,769.92-552,229,971.82
每股收益
其他综合收益-759,615.5-626,593.532,664.16-42,444.07
综合收益总额-243,802,463.22-972,884,369.77-599,594,105.76-552,272,415.89
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,112,716,986.292,038,604,874.891,945,024,390.541,880,685,962.88
非流动资产:
非流动资产合计2,455,630,290.752,517,237,523.12,582,064,872.562,587,873,276.49
资产总计4,568,347,277.044,555,842,397.994,527,089,263.14,468,559,239.37
流动负债:
流动负债合计2,411,812,766.242,258,603,546.692,158,018,752.662,083,832,217.97
非流动负债:
非流动负债合计1,867,323,589.211,764,236,022.821,423,488,042.11,381,148,199.93
负债合计4,279,136,355.454,022,839,569.513,581,506,794.763,464,980,417.9
所有者权益(或股东权益):
归属于母公司股东权益合计106,815,052.75349,507,699.53761,099,851.75818,070,486.77
股东权益合计289,210,921.59533,002,828.48945,582,468.341,003,578,821.47
负债和股东权益合计4,568,347,277.044,555,842,397.994,527,089,263.14,468,559,239.37
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计127,734,377.54995,140,217.2862,766,573.45554,782,686.31
经营活动现金流出小计361,897,548.661,285,363,383.62965,798,043.04588,707,146.94
经营活动产生的现金流量净额-234,163,171.12-290,223,166.42-103,031,469.59-33,924,460.63
投资活动产生的现金流量:
投资活动现金流入小计7,407,853.07230,227,288.71182,405,570.1242,175,778.45
投资活动现金流出小计106,963,398.47429,542,270.14383,466,693.34142,401,820.06
投资活动产生的现金流量净额-99,555,545.4-199,314,981.43-201,061,123.22-100,226,041.61
筹资活动产生的现金流量:
筹资活动现金流入小计924,980,0003,265,810,0001,685,840,0001,167,140,000
筹资活动现金流出小计631,554,858.052,473,885,150.061,168,592,549.64871,776,140.15
筹资活动产生的现金流量净额293,425,141.95791,924,849.94517,247,450.36295,363,859.85
汇率变动对现金及现金等价物的影响-2,610,067.84-3,613,540.5-1,291,825.48-153,575.87
现金及现金等价物净增加额-42,903,642.41298,773,161.59211,863,032.07161,059,781.74
期末现金及现金等价物余额1,483,435,684.411,526,339,326.821,439,429,197.31,388,625,946.97
补充资料:
现金及现金等价物的净增加额-298,773,161.59-161,059,781.74
最新报告期:2026-05-06
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
华西证券孙子豪,崔文亮-1.10-0.630.102026-05-06
东方证券张坤,伍云飞,胡俊涛-1.79-1.240.232026-04-02
野村东方国际证券孔令岩,肖鸿德-1.41-0.600.392026-04-02
中信建投袁清慧-1.40-0.38-0.192026-03-30
财通证券华挺-1.28-0.39-0.432026-03-26
TOP↑